1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
PHS 2024-2 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44]) is sponsored by National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA).
This omnibus solicitation supports investigator-initiated SBIR grant applications from small business concerns with R&D expertise to contribute to NIH, CDC, or FDA mission needs and SBIR program objectives. It offers non-dilutive funding for early-stage research and development.
Get alerted about grants like this
Save a search for “National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA)” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed) Agency: National Institutes of Health Assistance Listings: 93.
143 -- NIEHS Superfund Hazardous Substances_Basic Research and Education 93. 142 -- NIEHS Hazardous Waste Worker Health and Safety Training 93. 865 -- Child Health and Human Development Extramural Research 93.
307 -- Minority Health and Health Disparities Research 93. 113 -- Environmental Health 93. 213 -- Research and Training in Complementary and Integrative Health 93.
837 -- Cardiovascular Diseases Research 93. 859 -- Biomedical Research and Research Training 93. 846 -- Arthritis, Musculoskeletal and Skin Diseases Research 93.
840 -- Translation and Implementation Science Research for Heart, Lung, Blood Diseases, and Sleep Disorders 93. 350 -- National Center for Advancing Translational Sciences 93. 242 -- Mental Health Research Grants 93.
361 -- Nursing Research 93. 273 -- Alcohol Research Programs 93. 879 -- Medical Library Assistance 93.
279 -- Drug Abuse and Addiction Research Programs 93. 172 -- Human Genome Research 93. 121 -- Oral Diseases and Disorders Research 93.
394 -- Cancer Detection and Diagnosis Research 93. 847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research 93. 395 -- Cancer Treatment Research 93.
173 -- Research Related to Deafness and Communication Disorders 93. 855 -- Allergy and Infectious Diseases Research 93. 867 -- Vision Research 93.
351 -- Research Infrastructure Programs 93. 393 -- Cancer Cause and Prevention Research 93. 839 -- Blood Diseases and Resources Research 93.
233 -- National Center on Sleep Disorders Research 93. 838 -- Lung Diseases Research 93. 286 -- Discovery and Applied Research for Technological Innovations to Improve Human Health 93.
853 -- Extramural Research Programs in the Neurosciences and Neurological Disorders Last Updated: April 1, 2025 View version history on Grants.
gov This Notice of Funding Opportunity (NOFO), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications.
United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH, CDC, and FDA awarding components identified in this NOFO are encouraged to submit SBIR grant applications in response to identified topics (see SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA).
This Parent Funding Opportunity Announcement does not accept clinical trials. Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. Grantor contact information See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
File name Description Last updated PA-24-245-Full-Announcement. html PA-24-245 Full Announcement Text Link to additional information https://grants. nih.
gov/grants/guide/pa-files/PA-24-245. html Archived: October 5, 2025 Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Income security and social services
Based on current listing details, eligibility includes: U.S. small business concerns organized for profit, with a place of business in the United States, that meet SBA size standards. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Phase I: up to $306,872; Phase II: up to $2,045,816. Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
Past winners and funding trends for this program
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) is sponsored by National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA). This program provides funding to U. S. -owned and operated small businesses to develop promising technologies and products that align with the missions of NIH, CDC, and FDA to enhance health and well-being.
Small Business Innovation Research (SBIR) Program (Parent SBIR [R43/R44] Clinical Trial Optional) is sponsored by National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Food and Drug Administration (FDA). This program supports U. S. -owned and operated small businesses in developing promising technologies and products that support the missions of NIH, CDC, and FDA.